» Articles » PMID: 10220462

The First-nucleotide Binding Domain of the Cystic-fibrosis Transmembrane Conductance Regulator is Important for Inhibition of the Epithelial Na+ Channel

Overview
Specialty Science
Date 1999 Apr 29
PMID 10220462
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The cystic-fibrosis transmembrane conductance regulator (CFTR) functions as a cAMP-regulated Cl- channel and as a regulator of other membrane conductances. cAMP-dependent activation of CFTR inhibits epithelial Na+ channels (ENaC). The specificity of interaction between CFTR and ENaC was examined by coexpression of ENaC and ATP-binding cassette (ABC) proteins other than CFTR. In addition, we identified domains within CFTR that are of particular importance for the inhibition of ENaC. To that end, two-electrode voltage-clamp experiments were performed on Xenopus oocytes coexpressing ENaC together with CFTR, the multidrug resistance protein MDR1, the sulfonyl urea receptor SUR1, or the cadmium permease YCF1. Except for CFTR, none of the other ABC proteins were able to inhibit ENaC. Several truncated versions of CFTR were examined for their inhibitory effects on ENaC. In fact, it is shown that C-terminal truncated CFTR is able to inhibit ENaC on activation by intracellular cAMP. Moreover, the data also show that an intact first-nucleotide binding domain (NBF-1) is important for inhibition of ENaC. We conclude that NBF-1 of CFTR contains a CFTR-specific regulatory site that down-regulates ENaC. It is speculated that this regulatory site also is needed for CFTR-mediated interactions with other membrane proteins and that it is not present in NBF-1 of other ABC proteins.

Citing Articles

Impaired Regulatory Volume Decrease and Characterization of Underlying Volume-Activated Currents in Cystic Fibrosis Human Cholangiocyte Cell Line.

Chen B, Jefferson D, Cho W J Membr Biol. 2022; 255(2-3):261-276.

PMID: 35098342 DOI: 10.1007/s00232-022-00216-2.


Quantitative phase imaging to study transmembrane water fluxes regulated by CFTR and AQP3 in living human airway epithelial CFBE cells and CHO cells.

Llinares J, Cantereau A, Froux L, Becq F PLoS One. 2020; 15(5):e0233439.

PMID: 32469934 PMC: 7259668. DOI: 10.1371/journal.pone.0233439.


Impact of , adenosine triphosphate-binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers.

Zhou L, Chen L, Wang Y, Huang J, Yang G, Tan Z J Ginseng Res. 2019; 43(3):460-474.

PMID: 31308818 PMC: 6606825. DOI: 10.1016/j.jgr.2018.04.003.


SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration.

Webster M, Reidel B, Tan C, Ghosh A, Alexis N, Donaldson S Eur Respir J. 2018; 52(4).

PMID: 30190268 PMC: 6547379. DOI: 10.1183/13993003.00668-2018.


Pulmonary epithelial barrier function: some new players and mechanisms.

Brune K, Frank J, Schwingshackl A, Finigan J, Sidhaye V Am J Physiol Lung Cell Mol Physiol. 2015; 308(8):L731-45.

PMID: 25637609 PMC: 4747906. DOI: 10.1152/ajplung.00309.2014.


References
1.
Kunzelmann K, Kiser G, Schreiber R, Riordan J . Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 1997; 400(3):341-4. DOI: 10.1016/s0014-5793(96)01414-7. View

2.
Short D, Trotter K, Reczek D, Kreda S, BRETSCHER A, Boucher R . An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem. 1998; 273(31):19797-801. DOI: 10.1074/jbc.273.31.19797. View

3.
Annereau J, Wulbrand U, Vankeerberghen A, Cuppens H, Bontems F, Tummler B . A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 1997; 407(3):303-8. DOI: 10.1016/s0014-5793(97)00363-3. View

4.
Orlando R, Powell D, Croom R, Berschneider H, Boucher R, Knowles M . Colonic and esophageal transepithelial potential difference in cystic fibrosis. Gastroenterology. 1989; 96(4):1041-8. DOI: 10.1016/0016-5085(89)91621-1. View

5.
Boucher R, Cotton C, Gatzy J, Knowles M, Yankaskas J . Evidence for reduced Cl- and increased Na+ permeability in cystic fibrosis human primary cell cultures. J Physiol. 1988; 405:77-103. PMC: 1190965. DOI: 10.1113/jphysiol.1988.sp017322. View